Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

Clinical calculator summary

MIPI (Mantle Cell Lymphoma)

The MIPI is the standard prognostic tool for patients with advanced stage Mantle Cell Lymphoma (MCL).

Evidence-based context for fast calculator use

Purpose:
MIPI calculates prognosis in advanced mantle cell lymphoma using age, ECOG, LDH, and WBC to guide treatment intensity and trial selection.
Population:
patients with the specific hematologic diagnosis and disease phase described by the model
Factors:
Age, ECOG Performance Status, Serum LDH, LDH Upper Limit of Normal, WBC Count
Reference:
Hoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558-565.
HomeMIPI (Mantle Cell Lymphoma)
Pin your most used calculators here by clicking the star in the dropdown.

MIPI (Mantle Cell Lymphoma)

years
U/L
U/L
x10⁹/L

Clinical Context & Background

The MIPI is the standard prognostic tool for patients with advanced stage Mantle Cell Lymphoma (MCL). It uses a formula based on continuous variables (Age, ECOG, LDH, WBC) to calculate a prognostic score.
Primary Source EvidenceHoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558-565.
Formula Logic
Score = [0.03535 x Age] + [0.6978 (if ECOG > 1)] + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC)]

Reference Data

Risk GroupMIPI ScoreMedian Survival (Historical)
Low Risk< 5.7Not reached (5y OS 60%)
Intermediate Risk5.7 - 6.251 months
High Risk≥ 6.229 months

Clinical Workflow

Use, Interpret, And Continue The Patient Pathway

Expand for workflow guidance, limitations, examples, and related next steps.

When To Use

  • Use MIPI (Mantle Cell Lymphoma) when mIPI calculates prognosis in advanced mantle cell lymphoma using age, ECOG, LDH, and WBC to guide treatment intensity and trial selection.
  • Confirm that the patient, diagnosis, disease phase, and available inputs match the cited model before calculation.

How To Interpret

  • Interpret the displayed result using the calculator-specific formula and reference table, spanning Low Risk through High Risk.
  • A boundary result should prompt input verification and clinical review rather than false precision.

What To Do Next

  • Confirm morphology, molecular/cytogenetic data, treatment timing, laboratory units, and the current disease-specific guideline before acting.
  • Document the inputs, result, timing, and clinical context so the assessment can be reproduced.

Limitations

  • Hematology scores are diagnosis-, phase-, and treatment-specific and should not be transferred between diseases.
  • The result supports clinician judgment and does not independently determine treatment.

Validated Population

patients with the specific hematologic diagnosis and disease phase described by the model

How to apply this result

For a representative case, verify Age, ECOG Performance Status, Serum LDH, calculate the result, and confirm that its classification matches the highlighted reference band before continuing the disease-specific pathway.

Hematology hubContinue to related calculators and clinical workflow resources.

Share This Calculator

Share:

Related Tools

NCCN-IPI (Lymphoma)CLL-IPIIPS (Hodgkin Lymphoma)

Frequently Asked Questions

When should MIPI (Mantle Cell Lymphoma) be used?

Use it for patients with the specific hematologic diagnosis and disease phase described by the model when all required inputs and the intended clinical setting are confirmed.

Can MIPI (Mantle Cell Lymphoma) determine treatment by itself?

No. Interpret the result with the cited evidence, complete clinical assessment, current guidelines, and patient-specific goals.

Evidence-based oncology decision support. Verify with clinical guidelines.